02218nam a2200421 i 4500001001300000003000600013005001700019007001400036008004100050040003000091042000800121043001200129074001600141086002100157088008600178110011800264245025500382246005700637264006000694300002700754336000800781337001600789338001900805500003600824500002400860500002500884504004100909533010600950776019001056776019101246050002101437610007201458650007101530650007101601650003301672650005801705655003301763on1061559561OCoLC20181218140958.0he bmb024bbca181107s2018    dcu     bb   f000 0 eng c  aPUCPRbengerdacGPOdMvI  apcc  an-us---  a1027-B (MF)0 aY 4.V 64/3:115-4  aSerial no. 115-4 (United States. Congress. House. Committee on Veterans' Affairs)1 aUnited States.bCongress.bHouse.bCommittee on Veterans' Affairs.bSubcommittee on Oversight and Investigations,10aAssessing VA's risks for drug diversion :bhearing before the Subcommittee on Oversight and Investigations of the Committee on Veterans' Affairs, U.S. House of Representatives, One Hundred Fifteenth Congress, first session, Monday, February 27, 2017.3 aAssessing Veterans Affairs' risks for drug diversion 1aWashington :bU.S. Government Publishing Office,c2018.  aiii, 41 pages ;c24 cm  btxt  bh2rdamedia  bhe2rdacarrier  aShipping list no.: 2018-0188-M.  a"Serial no. 115-4."  aCRDP Program record.  aIncludes bibliographical references.  aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2018]e1 microfiche : negative.08iPrint version:aUnited States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Oversight and Investigations.tAssessing VA's risks for drug diversionw(OCoLC)103907992208iOnline version:aUnited States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Oversight and Investigations.tAssessing VA's risks for drug diversionw(OCoLC)1039079947 4aKF27b.V462 201710aUnited States.bVeterans Health AdministrationxRules and practice. 0aHospital pharmaciesxSecurity measureszUnited StatesxEvaluation. 0aVeterans' hospitalsxSecurity measureszUnited StatesxEvaluation. 0aOpioid abusezUnited States. 0aDrugsxPrescribingxCorrupt practiceszUnited States. 7aLegislative hearings.2lcgft